CatallaxCore
← Back to bills

HB 19-1296

failed

Prescription Drug Cost Reduction Measures

Summary

Section 1 of the bill enacts the "Colorado Prescription Drug Cost Reduction Act of 2019", which requires: Health insurers, starting in 2020, to submit to the commissioner of insurance (commissioner) information regarding prescription drugs covered under their health insurance plans that the plan paid for in the preceding calendar year, including information about rebates received from prescription drug manufacturers, a certification regarding how rebates were accounted for in insurance premiums, and a list of all pharmacy benefit management firms (PBMs) with whom they contract; Prescription drug manufacturers to notify the commissioner, state purchasers, health insurers, and PBMs when the manufacturer, on or after January 1, 2020, increases the price of certain prescription drugs by more than specified amounts or introduces a new specialty drug in the commercial market; Prescription drug manufacturers, within 15 days after the end of each calendar quarter that starts on or after January 1, 2020, to provide specified information to the commissioner regarding the drugs about which the manufacturer notified purchasers; Health insurers or, if applicable, PBMs to annually report specified information to the commissioner regarding rebates and administrative fees received from manufacturers for prescription drugs for which they received the required notice from a manufacturer; and Certain nonprofit organizations to compile and submit to the commissioner an annual report indicating the amount of each payment, donation, subsidy, or thing of value received by the nonprofit organization or its executive director, chief operating officer, board of directors, or any member of the board of directors from a prescription drug manufacturer, PBM, or health insurer and the percentage of the nonprofit organization's total gross income that is attributable to those payments, donations, subsidies, or things of value. The commissioner is required to post the information received from health insurers, prescription drug manufacturers, PBMs, and nonprofit organizations on the division of insurance's website, excluding any information that is proprietary. Additionally, the commissioner, or a disinterested third-party contractor, is to analyze the data reported by health insurers, prescription drug manufacturers, PBMs, and nonprofit organizations and other relevant information to determine the effect of prescription drug costs on health insurance premiums. The commissioner is to publish a report each year, submit the report to the governor and specified legislative committees, and present the report during annual "State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act" hearings. The commissioner is authorized to adopt rules as necessary to implement the requirements of the bill. Section 2 prohibits PBMs from retroactively reducing payment on a clean claim submitted by a pharmacy unless the PBM determines, through an audit conducted in accordance with state law, that the claim was not a clean claim. Health insurers that contract with PBMs must ensure that the PBMs are complying with this prohibition and the reporting requirements and are subject to penalties for failure to do so. Section 3 requires a carrier to reduce the cost sharing a covered person is required to pay for prescription drugs by an amount equal to the greater of 51% of the average aggregate rebates received by the carrier for all prescription drugs, including price protection rebates, or an amount that ensures cost sharing will not exceed 125% of the carrier's cost for the prescription drug. Under sections 5 and 6 , a prescription drug manufacturer that fails to notify purchasers or fails to report required data to the commissioner is subject to discipline by the state board of pharmacy, including a penalty of up to $10,000 per day for each day the manufacturer fails to comply with the notice or reporting requirements. The commissioner is to report manufacturer violations to the state board of pharmacy. Additionally, health insurers that fail to report the required data are subject to a fine of up to $10,000 per day. Sections 7 and 8 of the bill make conforming amendments necessary to harmonize the bill with the title 12 recodification bill, House Bill 19-1172.(Note: This summary applies to this bill as introduced.) Read More

Details

Chamber
House
First action
2019-03-29
Latest action
2019-05-09
Last action desc.
House Committee on Appropriations Lay Over Unamended - Amendment(s) Failed
OpenStates
View source ↗

Sponsors

Related Legislation

This bill affects (16)

amends
HB 19-1172(2019A)· signed
Title 12 Recodification And Reorganization
amends
HB 19-1242(2019A)· signed
Board Of Pharmacy Regulate Pharmacy Technicians
relates
SB 17-044(2017A)· signed
Reporting Requirements By DORA To General Assembly
relates
SB 17-249(2017A)· signed
Sunset Division Of Insurance
relates
HB 19-1168(2019A)· signed
State Innovation Waiver Reinsurance Program
relates
SB 17-003(2017A)· signed
Repeal Colorado Health Benefit Exchange
relates
HB 18-1311(2018A)· signed
Single Geographic Rating Area Individual Health Plan
relates
HB 19-1233(2019A)· signed
Investments In Primary Care To Reduce Health Costs
relates
HB 19-1269(2019A)· signed
Mental Health Parity Insurance Medicaid
relates
SB 17-057(2017A)· failed
Colorado Healthcare Affordability & Sustainability Enterprise
relates
SB 17-267(2017A)· signed
Sustainability Of Rural Colorado
relates
SB 17-242(2017A)· signed
Modernize Behavioral Health Terminology in Colorado Revised Statutes
relates
SB 18-131(2018A)· signed
State Employees Group Benefits Act Modifications
relates
HB 19-1172(2019A)· signed
Title 12 Recodification And Reorganization
relates
HB 18-1392(2018A)· signed
State Innovation Waiver Reinsurance Program
relates
HB 19-1242(2019A)· signed
Board Of Pharmacy Regulate Pharmacy Technicians

Affected by (15)

amends
SB 24-176(2024A)· signed
Update Medicaid Member Terminology
amends
HB 21-1232(2021A)· signed
Standardized Health Benefit Plan Colorado Option
amends
HB 25-1222(2025A)· signed
Preserving Access to Rural Independent Pharmacies
amends
HB 23-1227(2023A)· signed
Enforce Laws Against Pharmacy Benefit Managers
amends
SB 23-179(2023A)· signed
Dental Plans Medical Loss Ratio
amends
HB 22-1289(2022A)· signed
Health Benefits For Colorado Children And Pregnant Persons
amends
SB 25-270(2025A)· signed
Enterprise Nursing Facility Provider Fees
amends
HB 24-1293(2024A)· signed
Voluntary Payroll Deductions for State Employees
amends
HB 26-1198(2026A)· signed
Access to Veterinary Care
amends
SB 22-052(2022A)· signed
Medical Assistance Income Eligibility Requirements
relates
SB 23-041(2023A)· signed
Prescription Drugs For Off-label Use
relates
HB 23-1195(2023A)· signed
Automated Pharmacy Dispensing System
repeals
HB 22-1264(2022A)· signed
Change Food And Drug Administration To FDA
repeals
SB 19-241(2019A)· signed
Revisor's Bill
repeals
HB 26-1182(2026A)· signed
Sunset Veterinary Pharmaceutical Advisory Committee